Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Rush Health and Humana Sign Medicare Network Agreement: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Rush Health and Humana Sign Medicare Network Agreement


Clinically-integrated physician and hospital network Rush Health and leading health and well-being company Humana Inc. (NYSE: HUM) today announced an agreement to expand access to quality

Acadia Healthcare Announces Launch of $475 Million Senior Notes Offering: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Acadia Healthcare Announces Launch of $475 Million Senior Notes Offering


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (the “Company” or “Acadia”) announced today that it has launched a private offering (the “Offering”) of senior notes due 2029 (the “Notes”), subject

Acadia Healthcare Provides an Update on the U.K. Sale Process: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Acadia Healthcare Provides an Update on the U.K. Sale Process


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (the “Company” or “Acadia”) today provides an update on the sale process for the U.K. business. The Company previously suspended the sale process due

Simulations Plus Extends Partnership with Large Pharmaceutical Company to Further Expand High-Throughput PBPK Capabilities in ADMET Predictor®: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus Extends Partnership with Large Pharmaceutical Company to Further Expand High-Throughput PBPK Capabilities in ADMET Predictor®


Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that

Quidel Corporation Statement on President Trump’s Announcement of Coronavirus Testing Strategy
Quidel Corporation Statement on President Trump’s Announcement of Coronavirus Testing Strategy


Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, issued the following statement

LivaNova to Host Conference Call for Third Quarter 2020 Results: https://mms.businesswire.com/media/20191101005329/en/555341/5/LN-Logo-Main-PANTONE.jpg
LivaNova to Host Conference Call for Third Quarter 2020 Results


LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its third quarter 2020 results on Thursday, October 29, 2020 at 12

Three Quarters of ACOs in Premier Inc. Population Health Management Collaborative Achieve Savings for Medicare: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
Three Quarters of ACOs in Premier Inc. Population Health Management Collaborative Achieve Savings for Medicare


Three quarters (75 percent) of Premier Population Health Management Collaborative (PHMC) accountable care organizations (ACOs) participating in the Medicare Shared Savings Program (MSSP) earned

Illumina to Announce Third Quarter 2020 Financial Results on Thursday, October 29, 2020
Illumina to Announce Third Quarter 2020 Financial Results on Thursday, October 29, 2020


Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for the third quarter 2020 following the close of market on Thursday, October 29, 2020.



On the same day, at 2:00 pm Pacific

The Ohio State University Wexner Medical Center and Humana Announce Medicare Network Agreement: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
The Ohio State University Wexner Medical Center and Humana Announce Medicare Network Agreement


The Ohio State University Wexner Medical Center and Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, have signed an agreement to expand access to in-network

Dexcom Signs Multi-Year Collaboration Agreement with the University of Virginia to Advance Type 1 and Type 2 Diabetes Research: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Signs Multi-Year Collaboration Agreement with the University of Virginia to Advance Type 1 and Type 2 Diabetes Research


DexCom, Inc. (NASDAQ:DXCM) today announced it has signed a five-year collaboration agreement with the University of Virginia to advance its research and development efforts on continuous glucose

Hanger Announces Appointment of Dr. Mark M. Jones to Board of Directors
Hanger Announces Appointment of Dr. Mark M. Jones to Board of Directors


Hanger, Inc. (NYSE: HNGR) (the "Company") today announced that Mark M. Jones, MD has been appointed to its Board of Directors, increasing the size of the Board to ten members, effective

Illumina to Webcast Upcoming Investor Conference Presentation
Illumina to Webcast Upcoming Investor Conference Presentation


Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast.



Cowen’s Liquid Biopsy

EOS imaging Reports Its 2020 Half-year Financial Results
EOS imaging Reports Its 2020 Half-year Financial Results


Regulatory News:



EOS imaging (Euronext, FR0011191766 - EOSI - PEA-PME eligible) (Paris:EOSI), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and

Veeva and Bioforum Partner with RedHill Biopharma to Maximize Value of Opaganib Phase 2/3 COVID-19 Clinical Data
Veeva and Bioforum Partner with RedHill Biopharma to Maximize Value of Opaganib Phase 2/3 COVID-19 Clinical Data


Veeva Systems (NYSE: VEEV) (“Veeva”) and Bioforum today announced their collaboration with RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill”) on a global Phase 2/3 clinical study evaluating opaganib

Simulations Plus Partners with Large Pharmaceutical Company to Validate AI-Driven Drug Design Capabilities in ADMET Predictor®
Simulations Plus Partners with Large Pharmaceutical Company to Validate AI-Driven Drug Design Capabilities in ADMET Predictor®


Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that

Dexcom G6 Continuous Glucose Monitoring System Now Available at Veterans Affairs Pharmacies Across the United States
Dexcom G6 Continuous Glucose Monitoring System Now Available at Veterans Affairs Pharmacies Across the United States


DexCom, Inc. (NASDAQ:DXCM) announced today the Dexcom G6 Continuous Glucose Monitoring (CGM) System is now available at Veterans Affairs (VA) pharmacies, improving access to CGM and empowering

Waters Establishes Flagship Innovation and Research Laboratory in Cambridge, MA
Waters Establishes Flagship Innovation and Research Laboratory in Cambridge, MA


Waters Corporation (NYSE:WAT) announced this week at Biotech Week Boston the establishment of Immerse™ Cambridge, a new Waters' research laboratory in the heart of Cambridge’s Kendall Square

Illumina und die heilige GRAIL: Darum ist die Aktie abgestürzt!
Illumina und die heilige GRAIL: Darum ist die Aktie abgestürzt!

Der US-amerikanische Biotechdienstleister Illumina (WKN: 927079) hat kürzlich die vollständige Übernahme der seinerzeit selbst gegründeten Tochtergesellschaft GRAIL für 7,1 Milliarden US-Dollar

Veeva Commercial Cloud Selected by Idorsia to Accelerate Digital Engagement Globally
Veeva Commercial Cloud Selected by Idorsia to Accelerate Digital Engagement Globally


Veeva Systems (NYSE: VEEV) today announced that Idorsia Pharmaceuticals Ltd (SIX: IDIA) has selected Veeva Commercial Cloud to enable its digital field force in the U.S., Japan, and countries

Medis Selects Veeva CRM to Deliver Personalized Experiences to Healthcare Professionals
Medis Selects Veeva CRM to Deliver Personalized Experiences to Healthcare Professionals


Veeva Systems (NYSE: VEEV) today announced that Medis has switched to multichannel Veeva CRM in 15 countries across Central and Eastern Europe to advance its commercial strategy and drive more

Illumina to Acquire GRAIL to Launch New Era of Cancer Detection
Illumina to Acquire GRAIL to Launch New Era of Cancer Detection


Illumina, Inc. (NASDAQ: ILMN) and GRAIL, a healthcare company whose mission is focused on multi-cancer early detection, today announced they have entered into a definitive agreement under which

American Renal Associates Holdings, Inc. Announces Settlement of Shareholder Derivative Litigation
American Renal Associates Holdings, Inc. Announces Settlement of Shareholder Derivative Litigation


American Renal Associates Holdings, Inc. (NYSE: ARA) (the “Company”), a leading provider of outpatient dialysis services, is pleased to announce that the Company has received preliminary approval

Humana and AtlantiCare Sign Medicare Network Agreement in Southeastern New Jersey
Humana and AtlantiCare Sign Medicare Network Agreement in Southeastern New Jersey


Leading health and well-being company Humana Inc. (NYSE: HUM) has signed an agreement with integrated healthcare system AtlantiCare that offers in-network access for Humana Medicare Advantage

Agilent Expands Line of Innovative Flow Cytometers with the NovoCyte Penteon
Agilent Expands Line of Innovative Flow Cytometers with the NovoCyte Penteon


Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent NovoCyte Penteon, a sensitive flow cytometer with five lasers and up to 30 fluorescence channels. The NovoCyte Penteon

Veeva Forms Board Committee to Explore Becoming a Public Benefit Corporation
Veeva Forms Board Committee to Explore Becoming a Public Benefit Corporation


Veeva Systems (NYSE: VEEV) today announced it has formed a board committee to explore becoming a public benefit corporation (PBC). The Committee will seek input from shareholders, customers, and